Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>
Rachel L. Batterham(University College Hospital), Stephen R. Bloom(Imperial College London), Sylvia Ellis(Hammersmith Hospital), Mark A. Cohen(Vanderbilt University), Gary Frost(Imperial College London), Carel W. le Roux(University College Dublin), Mohammad A. Ghatei(Hammersmith Hospital), Dominic J. Withers(Imperial College London)
Cited by 1,582
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
|Nature Communications|2014|1.7k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Human distribution and release of a putative new gut hormone, peptide YY
|Gastroenterology|1985|1.1k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k